Nifty

:

17629.50

Sensex

:

59141.16

110.05 (0.63%)
417.96 (0.71%)

Login

Nifty
Sensex

:
:

17629.50
59141.16

110.05 (0.63%)
417.96 (0.71%)

Glaxosmithkline Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

56/99

BSE: 500660 | NSE: GLAXO

Watchlist

NSE BSE

1572.95

16-Sep-2021

Open
High
Low
Previous Close

1560.00
1604.90
1560.00
1559.20

Volume
Traded Value (lacs)
52 Week High
52 Week Low

201776
3202.74
1801.00
1376.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

26,345.18
71.51
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

25,187.22
1.93%
16.26

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
1.92
0.75

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
10.66
2.97

PAT CAGR (%)

10 Years
5 Years
3 Years

-
1.24
-7.01

P:E (Median)

8 Years
5 Years
3 Years

60.41
62.08
64.62

P:BV (Average)

8 Years
5 Years
3 Years

13.19
12.87
13.57

EV:EBITDA (Average)

8 Years
5 Years
3 Years

35.04
35.69
33.55

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 773.46 648.65 19.24% 807.27 775.88 4.05% 858.42 778.68 10.24% 879.39 882.10 -0.31%
Expenses 622.77 534.30 16.56% 638.48 601.80 6.10% 651.63 654.03 -0.37% 674.37 687.86 -1.96%
EBITDA 150.69 114.35 31.78% 168.79 174.08 -3.04% 206.79 124.65 65.90% 205.02 194.24 5.55%
EBIDTM 19.48% 17.63% 20.91% 22.44% 24.09% 16.01% 23.31% 22.02%
Other Income 31.73 57.79 -45.09% 29.61 15.16 95.32% 13.87 16.25 -14.65% 8.92 15.61 -42.86%
Interest 0.79 1.08 -26.85% 0.63 1.51 -58.28% 0.94 2.98 -68.46% 0.88 0.92 -4.35%
Depreciation 17.71 21.77 -18.65% 17.85 22.59 -20.98% 17.71 18.33 -3.38% 21.96 22.70 -3.26%
PBT 163.92 149.29 9.80% 60.92 176.41 -65.47% 212.54 -617.31 - 126.97 587.37 -78.38%
Tax 43.52 38.33 13.54% 48.18 38.47 25.24% 55.19 26.83 105.70% 50.47 84.58 -40.33%
PAT 120.40 110.96 8.51% 12.74 137.94 -90.76% 157.35 -644.14 - 76.50 502.79 -84.78%
PATM 15.57% 17.11% 1.58% 17.78% 18.33% -82.72% 8.70% 57.00%
EPS 7.11 6.55 8.55% 0.75 8.14 -90.79% 9.29 -38.02 - 4.52 29.68 -84.77%

Description Jun 21 Jun 20 Var% Mar 21 Mar 20 Var% Dec 20 Dec 19 Var% Sep 20 Sep 19 Var%
Net Sales 789.99 648.59 21.80% 813.75 775.80 4.89% 857.20 778.59 10.10% 879.32 882.02 -0.31%
Expenses 638.32 534.52 19.42% 642.86 602.24 6.74% 651.69 654.20 -0.38% 674.46 688.01 -1.97%
EBITDA 151.67 114.07 32.96% 170.89 173.56 -1.54% 205.51 124.39 65.21% 204.86 194.01 5.59%
EBIDTM 19.20% 17.59% 21.00% 22.37% 23.97% 15.98% 23.30% 22.00%
Other Income 31.73 57.92 -45.22% 29.60 15.82 87.10% 14.02 16.50 -15.03% 9.04 15.88 -43.07%
Interest 0.79 1.08 -26.85% 0.63 1.51 -58.28% 0.94 2.98 -68.46% 0.88 0.92 -4.35%
Depreciation 17.71 21.77 -18.65% 17.85 22.59 -20.98% 17.71 18.33 -3.38% 21.96 22.70 -3.26%
PBT 164.90 149.14 10.57% 63.01 176.55 -64.31% 211.41 -634.32 - 126.93 587.41 -78.39%
Tax 43.82 38.31 14.38% 48.68 38.48 26.51% 54.90 26.84 104.55% 50.46 84.66 -40.40%
PAT 121.08 110.83 9.25% 14.33 138.07 -89.62% 156.51 -661.16 - 76.47 502.75 -84.79%
PATM 15.33% 17.09% 1.76% 17.80% 18.26% -84.92% 8.70% 57.00%
EPS 7.15 6.54 9.33% 0.85 8.15 -89.57% 9.24 -39.03 - 4.51 29.68 -84.80%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11
Net Sales 3,318.54 3,193.74 3,224.68 3,128.53 2,871.69 2,902.99 2,826.21 3,345.97 2,591.16 2,671.83 2,416.86 Net Sales Growth 7.56% -0.96% 3.07% 8.94% -1.08% 2.72% -15.53% 29.13% -3.02% 10.55% Cost Of Goods Sold 1,342.73 1,305.22 1,307.87 1,353.53 1,240.75 1,393.77 1,318.65 1,322.83 1,166.02 1,094.24 912.83 Gross Profit 1,975.81 1,888.51 1,916.81 1,775.01 1,630.93 1,509.22 1,507.56 2,023.14 1,425.14 1,577.58 1,504.03 GP Margin 59.54% 59.13% 59.44% 56.74% 56.79% 51.99% 53.34% 60.46% 55.00% 59.04% 62.23% Total Expenditure 2,587.25 2,498.78 2,566.23 2,522.05 2,363.25 2,483.05 2,349.46 2,777.18 2,114.09 1,901.95 1,675.46 Power & Fuel Cost - 26.08 33.36 27.94 26.44 27.82 25.97 31.17 23.85 22.50 26.70 % Of Sales - 0.82% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% 0.92% 0.84% 1.10% Employee Cost - 614.69 628.55 537.20 523.40 483.01 443.37 493.02 362.05 295.52 278.36 % Of Sales - 19.25% 19.49% 17.17% 18.23% 16.64% 15.69% 14.73% 13.97% 11.06% 11.52% Manufacturing Exp. - 106.53 107.88 115.19 110.55 108.26 117.67 365.85 127.72 113.57 111.16 % Of Sales - 3.34% 3.35% 3.68% 3.85% 3.73% 4.16% 10.93% 4.93% 4.25% 4.60% General & Admin Exp. - 118.77 164.31 178.51 203.43 194.72 154.34 177.98 134.79 125.55 107.78 % Of Sales - 3.72% 5.10% 5.71% 7.08% 6.71% 5.46% 5.32% 5.20% 4.70% 4.46% Selling & Distn. Exp. - 190.92 212.36 202.81 154.38 178.88 164.26 222.32 186.27 160.50 157.41 % Of Sales - 5.98% 6.59% 6.48% 5.38% 6.16% 5.81% 6.64% 7.19% 6.01% 6.51% Miscellaneous Exp. - 136.57 111.89 106.88 104.29 96.61 125.19 164.01 113.38 90.07 157.41 % Of Sales - 4.28% 3.47% 3.42% 3.63% 3.33% 4.43% 4.90% 4.38% 3.37% 3.36% EBITDA 731.29 694.96 658.45 606.48 508.44 419.94 476.75 568.79 477.07 769.88 741.40 EBITDA Margin 22.04% 21.76% 20.42% 19.39% 17.71% 14.47% 16.87% 17.00% 18.41% 28.81% 30.68% Other Income 84.13 110.19 77.56 101.48 53.52 72.01 122.25 257.53 246.31 243.07 200.93 Interest 3.24 3.53 6.34 0.55 0.19 0.25 0.42 0.47 0.33 0.33 0.33 Depreciation 75.23 79.28 82.68 48.59 37.99 26.35 24.95 25.35 19.88 17.84 20.41 PBT 564.35 722.33 646.99 658.82 523.78 465.35 573.63 800.50 703.17 994.78 921.60 Tax 197.36 192.17 212.45 238.35 189.60 174.30 201.41 276.98 227.44 269.30 168.45 Tax Rate 34.97% 34.96% 65.88% 35.91% 35.01% 34.10% 34.97% 37.00% 31.19% 31.81% 28.12% PAT 366.99 357.57 110.05 425.36 351.99 336.78 374.53 471.65 501.88 577.26 430.60 PAT before Minority Interest 366.99 357.57 110.05 425.36 351.99 336.78 374.53 471.65 501.88 577.26 430.60 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.06% 11.20% 3.41% 13.60% 12.26% 11.60% 13.25% 14.10% 19.37% 21.61% 17.82% PAT Growth 241.23% 224.92% -74.13% 20.84% 4.52% -10.08% -20.59% -6.02% -13.06% 34.06% EPS 21.66 21.11 6.50 25.11 20.78 19.88 22.11 27.84 29.63 34.08 25.42

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11
Net Sales 3,340.26 3,198.86 3,224.38 3,128.12 2,871.45 2,908.47 2,837.91 3,362.91 2,607.70 2,692.06 2,455.38 Net Sales Growth 8.27% -0.79% 3.08% 8.94% -1.27% 2.49% -15.61% 28.96% -3.13% 9.64% Cost Of Goods Sold 1,365.49 1,312.71 1,307.87 1,358.03 1,241.31 1,397.75 1,324.90 1,327.66 1,171.68 1,100.57 923.50 Gross Profit 1,974.77 1,886.15 1,916.51 1,770.09 1,630.14 1,510.72 1,513.02 2,035.25 1,436.02 1,591.49 1,531.87 GP Margin 59.12% 58.96% 59.44% 56.59% 56.77% 51.94% 53.31% 60.52% 55.07% 59.12% 62.39% Total Expenditure 2,607.33 2,503.53 2,567.13 2,527.32 2,365.66 2,489.49 2,359.64 2,788.33 2,124.49 1,915.22 1,693.90 Power & Fuel Cost - 26.08 33.36 27.94 26.44 27.82 25.97 31.17 23.85 22.50 26.70 % Of Sales - 0.82% 1.03% 0.89% 0.92% 0.96% 0.92% 0.93% 0.91% 0.84% 1.09% Employee Cost - 614.69 628.55 537.20 523.40 483.01 443.37 493.02 362.05 295.52 278.36 % Of Sales - 19.22% 19.49% 17.17% 18.23% 16.61% 15.62% 14.66% 13.88% 10.98% 11.34% Manufacturing Exp. - 106.55 107.89 115.55 110.55 108.26 118.09 367.24 127.78 113.62 111.44 % Of Sales - 3.33% 3.35% 3.69% 3.85% 3.72% 4.16% 10.92% 4.90% 4.22% 4.54% General & Admin Exp. - 118.87 164.51 178.60 204.45 195.08 154.85 178.21 135.34 126.10 108.51 % Of Sales - 3.72% 5.10% 5.71% 7.12% 6.71% 5.46% 5.30% 5.19% 4.68% 4.42% Selling & Distn. Exp. - 190.92 212.36 202.81 154.38 178.91 164.47 222.31 186.23 160.74 157.60 % Of Sales - 5.97% 6.59% 6.48% 5.38% 6.15% 5.80% 6.61% 7.14% 5.97% 6.42% Miscellaneous Exp. - 133.71 112.58 107.20 105.12 98.67 127.99 168.72 117.55 96.17 157.60 % Of Sales - 4.18% 3.49% 3.43% 3.66% 3.39% 4.51% 5.02% 4.51% 3.57% 3.58% EBITDA 732.93 695.33 657.25 600.80 505.79 418.98 478.27 574.58 483.21 776.84 761.48 EBITDA Margin 21.94% 21.74% 20.38% 19.21% 17.61% 14.41% 16.85% 17.09% 18.53% 28.86% 31.01% Other Income 84.39 110.58 79.01 102.32 54.54 73.07 123.18 258.80 222.30 223.90 186.59 Interest 3.24 3.53 6.34 0.55 0.19 0.25 0.42 0.47 0.33 0.33 0.33 Depreciation 75.23 79.28 82.68 48.59 37.99 26.35 24.95 25.35 19.88 17.84 20.41 PBT 566.25 723.10 647.25 653.97 522.17 465.46 576.08 807.56 685.30 982.58 927.33 Tax 197.86 192.35 212.55 237.28 189.24 174.37 202.25 279.27 229.78 272.48 176.20 Tax Rate 34.94% 34.94% 69.52% 34.76% 35.05% 34.11% 34.97% 36.96% 32.30% 32.66% 29.13% PAT 368.39 358.15 93.20 445.39 350.73 336.81 376.14 476.41 481.67 561.88 428.59 PAT before Minority Interest 368.39 358.15 93.20 445.39 350.73 336.81 376.14 476.41 481.67 561.88 428.59 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.03% 11.20% 2.89% 14.24% 12.21% 11.58% 13.25% 14.17% 18.47% 20.87% 17.46% PAT Growth 307.11% 284.28% -79.07% 26.99% 4.13% -10.46% -21.05% -1.09% -14.28% 31.10% EPS 21.75 21.14 5.50 26.29 20.70 19.88 22.20 28.12 28.43 33.17 25.30

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11
Shareholder's Funds 1,517.93 1,840.04 2,142.42 2,079.95 2,028.21 2,204.64 1,851.67 2,017.19 2,010.02 1,919.93 Share Capital 169.41 169.41 169.41 84.70 84.70 84.70 84.70 84.70 84.70 84.70 Total Reserves 1,348.53 1,670.63 1,973.01 1,995.25 1,943.51 2,119.94 1,766.97 1,932.49 1,925.31 1,835.23 Non-Current Liabilities 178.87 180.56 2,835.06 2,572.79 3,639.66 190.35 195.96 157.51 157.36 171.68 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.02 0.18 0.58 0.99 1.60 2.63 3.61 4.14 4.59 Long Term Provisions 258.25 260.49 2,893.17 2,673.01 3,726.49 283.90 270.96 241.04 234.79 223.56 Current Liabilities 1,297.32 1,002.07 2,800.62 2,945.16 878.32 574.86 1,105.86 883.07 835.75 857.98 Trade Payables 446.33 354.19 402.96 502.53 275.92 323.09 305.89 278.01 235.19 198.34 Other Current Liabilities 433.09 205.84 802.59 842.33 391.18 203.59 131.56 86.22 88.35 68.37 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 417.90 442.04 1,595.07 1,600.30 211.22 48.18 668.42 518.83 512.21 591.28 Total Liabilities 2,994.12 3,022.67 7,778.10 7,597.90 6,546.19 2,969.85 3,153.49 3,057.77 3,003.13 2,949.59 Net Block 384.27 756.59 429.99 322.81 252.71 204.04 123.06 100.07 89.40 99.13 Gross Block 614.71 1,452.35 559.05 405.89 299.09 228.36 319.19 299.08 272.04 271.66 Accumulated Depreciation 230.44 695.76 129.06 83.08 46.38 24.32 196.13 199.01 182.63 172.53 Non Current Assets 822.79 1,265.90 4,437.17 4,085.73 4,735.48 822.06 588.30 456.03 390.73 380.12 Capital Work in Progress 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 61.86 43.79 16.19 Non Current Investment 25.82 25.97 26.17 49.43 52.99 53.63 47.67 47.67 57.68 102.59 Long Term Loans & Adv. 392.45 356.05 2,970.52 2,785.85 3,817.84 296.66 291.23 232.87 189.69 152.93 Other Non Current Assets 7.03 7.17 7.84 4.75 6.47 0.06 11.12 13.55 10.18 9.27 Current Assets 2,171.33 1,756.78 3,340.93 3,512.17 1,810.70 2,147.80 2,565.18 2,601.73 2,612.40 2,569.48 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.00 44.91 57.21 Inventories 523.34 483.03 486.49 500.18 425.48 521.66 368.86 342.40 282.04 330.14 Sundry Debtors 215.60 99.80 120.49 146.96 170.80 126.56 100.32 96.39 115.90 85.31 Cash & Bank 1,157.68 1,066.41 1,155.33 1,279.69 882.23 1,377.68 1,898.02 2,027.14 2,038.78 1,984.09 Other Current Assets 274.70 48.43 111.96 78.51 332.19 121.90 197.99 125.80 130.77 112.73 Short Term Loans & Adv. 56.48 59.11 1,466.65 1,506.82 226.27 98.66 109.61 68.16 55.79 49.40 Net Current Assets 874.01 754.71 540.31 567.01 932.39 1,572.94 1,459.32 1,718.67 1,776.65 1,711.50 Total Assets 2,994.12 3,022.68 7,778.10 7,597.90 6,546.18 2,969.86 3,153.48 3,057.76 3,003.13 2,949.60

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11
Shareholder's Funds 1,499.08 1,820.60 2,139.83 2,057.33 2,006.86 2,183.25 1,828.98 1,989.73 2,006.83 1,935.70 Share Capital 169.41 169.41 169.41 84.70 84.70 84.70 84.70 84.70 84.70 84.70 Total Reserves 1,329.67 1,651.20 1,970.42 1,972.63 1,922.15 2,098.55 1,744.28 1,905.03 1,922.13 1,851.00 Non-Current Liabilities 178.68 180.19 2,860.37 2,632.47 3,699.70 3,498.32 197.04 158.59 158.45 172.78 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.02 0.18 0.58 0.99 1.60 2.63 3.61 4.14 4.59 Long Term Provisions 259.50 261.74 2,920.20 2,733.36 3,786.83 3,592.19 272.21 242.29 236.05 224.81 Current Liabilities 1,332.47 1,021.95 2,804.07 2,948.98 881.09 783.63 1,106.55 888.91 836.40 859.59 Trade Payables 464.47 357.06 405.81 505.86 278.93 327.74 308.04 285.63 237.37 200.58 Other Current Liabilities 450.11 222.85 802.71 842.35 390.47 202.82 130.09 84.13 86.82 67.25 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 417.90 442.04 1,595.54 1,600.77 211.69 253.08 668.42 519.15 512.21 591.77 Total Liabilities 3,010.23 3,022.74 7,804.27 7,638.78 6,587.65 6,465.20 3,132.57 3,037.23 3,001.68 2,968.07 Net Block 384.27 756.59 429.99 322.81 252.71 204.04 123.08 100.09 89.42 99.15 Gross Block 614.71 1,452.35 559.05 405.89 299.09 228.36 363.34 343.22 316.18 315.80 Accumulated Depreciation 230.44 695.76 129.06 83.08 46.38 24.32 240.26 243.13 226.76 216.65 Non Current Assets 807.58 1,247.87 4,445.06 4,103.26 4,752.54 4,087.05 545.58 413.30 355.01 363.01 Capital Work in Progress 13.21 120.12 1,002.64 922.90 605.46 267.67 115.22 61.86 43.79 16.19 Non Current Investment 1.35 1.49 1.69 1.84 5.40 6.04 0.06 0.06 10.06 54.98 Long Term Loans & Adv. 401.71 362.49 3,002.88 2,850.97 3,882.49 3,609.24 296.09 237.73 194.55 157.01 Other Non Current Assets 7.03 7.17 7.84 4.75 6.47 0.06 11.13 13.55 17.19 35.68 Current Assets 2,202.65 1,774.88 3,359.21 3,535.52 1,835.10 2,378.15 2,586.98 2,623.94 2,646.67 2,605.06 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.00 44.91 57.21 Inventories 546.70 483.03 486.49 500.18 425.80 525.87 375.58 346.97 285.15 333.44 Sundry Debtors 215.60 99.80 120.49 146.96 170.80 126.56 100.32 96.39 115.90 85.31 Cash & Bank 1,157.98 1,083.20 1,171.35 1,296.41 899.61 1,391.90 1,910.61 2,041.58 2,066.77 2,014.36 Other Current Assets 282.38 48.58 112.30 78.72 338.90 333.82 200.47 128.99 133.94 114.74 Short Term Loans & Adv. 57.64 60.27 1,468.58 1,513.25 232.20 310.58 112.04 71.19 58.18 50.12 Net Current Assets 870.18 752.93 555.14 586.54 954.01 1,594.52 1,480.43 1,735.03 1,810.27 1,745.46 Total Assets 3,010.23 3,022.75 7,804.27 7,638.78 6,587.64 6,465.20 3,132.56 3,037.24 3,001.68 2,968.07

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11
Cash From Operating Activity 594.87 490.97 411.18 474.77 232.28 138.27 340.88 267.42 293.63 321.56 PBT 722.33 646.99 658.82 523.78 465.35 573.63 800.50 703.17 994.78 921.60 Adjustment -25.25 14.20 -30.52 -11.15 -45.42 -95.08 -172.39 -180.38 -178.80 -153.72 Changes in Working Capital 63.03 43.59 -7.58 163.69 -29.47 -125.04 -30.17 1.66 38.79 -74.06 Cash after chg. in Working capital 760.11 704.78 620.71 676.33 390.46 353.51 597.94 524.44 854.76 693.82 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -146.91 -179.55 -194.15 -201.82 -160.86 -204.42 -250.13 -242.05 -313.81 -309.30 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -18.34 -34.26 -15.38 0.25 2.67 -10.82 -6.93 -14.97 -247.33 -62.96 Cash From Investing Activity 408.15 -63.10 -154.44 -107.01 303.08 499.09 177.62 197.98 -92.58 368.48 Net Fixed Assets 944.55 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 -45.11 -27.98 39.27 Net Investments 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 44.92 57.21 0.55 Others -536.55 -52.52 55.20 313.67 710.96 566.67 241.09 198.17 -121.81 328.66 Cash from Financing Activity -696.14 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 -490.08 -437.07 -391.82 Net Cash Inflow / Outflow 306.87 0.25 -101.62 61.12 24.59 -0.98 21.51 -24.68 -236.01 298.22 Opening Cash & Equivalents 98.03 97.78 199.40 138.27 113.68 114.66 93.50 137.07 373.08 74.86 Closing Cash & Equivalent 404.90 98.03 97.78 199.40 138.27 113.68 115.01 112.39 137.07 373.08

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11
Cash From Operating Activity 577.93 490.50 409.49 472.80 234.37 138.90 337.64 281.31 313.59 335.37 PBT 723.10 647.25 653.97 522.17 465.46 576.08 807.56 685.30 982.58 927.33 Adjustment -25.64 13.17 -31.36 -12.17 -46.47 -96.01 -173.66 -156.37 -159.63 -139.38 Changes in Working Capital 45.76 44.07 -4.19 164.56 -26.69 -124.41 -36.90 11.45 56.35 -73.09 Cash after chg. in Working capital 743.21 704.49 618.41 674.55 392.29 355.67 597.00 540.37 879.30 714.86 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -146.95 -179.72 -194.24 -202.01 -160.59 -205.95 -252.43 -244.09 -318.38 -316.53 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items -18.34 -34.26 -14.69 0.25 2.67 -10.82 -6.93 0.00 0.00 0.00 Cash From Investing Activity 418.59 -56.84 -153.45 -104.19 300.64 499.02 180.01 188.98 -109.65 358.03 Net Fixed Assets 944.55 -10.78 -232.90 -424.24 -408.52 -61.62 -73.47 -45.11 -27.98 39.27 Net Investments 0.15 0.20 23.26 3.56 0.64 -5.96 10.00 44.92 57.21 0.55 Others -526.11 -46.26 56.19 316.49 708.52 566.60 243.48 189.17 -138.88 318.21 Cash from Financing Activity -696.14 -427.62 -358.36 -306.63 -510.76 -638.33 -496.99 -494.14 -440.63 -394.81 Net Cash Inflow / Outflow 300.38 6.03 -102.33 61.97 24.24 -0.42 20.66 -23.85 -236.69 298.59 Opening Cash & Equivalents 104.81 98.78 201.10 139.13 114.89 115.30 94.93 137.67 374.36 75.77 Closing Cash & Equivalent 405.19 104.81 98.78 201.10 139.13 114.89 115.59 113.82 137.67 374.36

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11
Book Value (Rs.) 89.60 108.62 126.47 122.78 119.72 130.14 109.30 119.07 118.65 113.33 ROA 11.89% 2.04% 5.53% 4.98% 7.08% 12.23% 15.19% 16.56% 19.39% 10.83% ROE 21.30% 5.53% 20.15% 17.14% 15.91% 18.47% 24.38% 24.92% 29.38% 22.36% ROCE 32.95% 16.51% 31.45% 26.36% 24.14% 28.38% 38.65% 36.16% 43.00% 31.05% Fixed Asset Turnover 3.09 3.21 6.48 8.22 11.35 10.32 11.16 9.33 10.09 8.37 Receivable days 18.02 12.47 15.60 20.03 18.12 14.65 10.40 14.54 13.39 9.78 Inventory Days 57.51 54.87 57.56 58.34 57.72 57.50 37.61 42.77 40.75 45.18 Payable days 61.19 57.46 72.90 65.55 50.91 53.40 43.13 48.42 47.09 62.05 Cash Conversion Cycle 14.34 9.88 0.26 12.81 24.94 18.76 4.88 8.89 7.05 -7.09 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 156.67 51.90 1198.38 2865.01 2045.32 1368.05 1597.21 2205.05 2534.09 1830.74

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Dec 13 Dec 12 Dec 11
Book Value (Rs.) 88.49 107.47 126.31 121.44 118.46 128.88 107.96 117.45 118.46 114.26 ROA 11.87% 1.72% 5.77% 4.93% 5.16% 7.84% 15.44% 15.95% 18.82% 10.65% ROE 21.58% 4.71% 21.22% 17.26% 16.08% 18.75% 24.95% 24.10% 28.50% 22.05% ROCE 33.38% 15.76% 32.54% 26.56% 24.39% 28.82% 39.53% 35.54% 42.24% 31.05% Fixed Asset Turnover 3.10 3.21 6.48 8.21 11.38 9.59 9.82 8.13 8.74 7.40 Receivable days 17.99 12.47 15.60 20.03 18.09 14.59 10.35 14.45 13.29 9.62 Inventory Days 58.75 54.88 57.56 58.36 57.89 57.97 38.01 43.02 40.86 45.01 Payable days 62.30 57.89 73.24 66.07 51.56 53.81 43.72 49.18 47.40 62.14 Cash Conversion Cycle 14.44 9.45 -0.07 12.32 24.42 18.75 4.64 8.28 6.75 -7.51 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 156.89 49.26 1232.59 2856.45 2045.74 1373.88 1612.26 2146.51 2497.59 1848.25

Top Investors:

qualified institutional buyer

life insurance corporation of india

aditya birla sun life trustee private limited a/c aditya birla sun life nifty midcap 150 index fund

general insurance corporation of india

Annual Reports:

News Update:

GlaxoSmithKline Pharmaceuticals to transfer rights of Iodex and Ostocalcium brands to GSK Asia
27th Jul 2021, 09:16 AM

The transaction is expected to be completed before the end of the year
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback